Q00975 (CAC1B_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Voltage-dependent N-type calcium channel subunit alpha-1B Alternative name(s): Brain calcium channel III Short name=BIII Calcium channel, L type, alpha-1 polypeptide isoform 5 Voltage-gated calcium channel subunit alpha Cav2.2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 2339 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1B gives rise to N-type calcium currents. N-type calcium channels belong to the 'high-voltage activated' (HVA) group and are blocked by omega-conotoxin-GVIA (omega-CTx-GVIA) and by omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive to dihydropyridines (DHP), and omega-agatoxin-IVA (omega-Aga-IVA). Calcium channels containing alpha-1B subunit may play a role in directed migration of immature neurons. |
| Subunit structure | Multisubunit complex consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 ratio. The channel activity is directed by the pore-forming and voltage-sensitive alpha-1 subunit. In many cases, this subunit is sufficient to generate voltage-sensitive calcium channel activity. The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity. Interacts with RIMS1 and RIMBP2 By similarity. |
| Subcellular location | |
| Tissue specificity | Isoform Alpha-1b-1 and isoform Alpha-1b-2 are expressed in the central nervous system, but not in skeletal muscle or aorta. |
| Domain | Each of the four internal repeats contains five hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one positively charged transmembrane segment (S4). S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position. |
| Post-translational modification | Phosphorylated in vitro by CaM-kinase II, PKA, PKC and CGPK By similarity. |
| Sequence similarities | Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family. CACNA1B subfamily. [View classification] Contains 1 EF-hand domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Calcium transport Ion transport Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat Transmembrane Transmembrane helix |
| Ligand | ATP-binding Calcium Metal-binding Nucleotide-binding |
| Molecular function | Calcium channel Ion channel Voltage-gated channel |
| PTM | Disulfide bond Glycoprotein Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | membrane depolarization Traceable author statement. Source: Reactome synaptic transmissionTraceable author statement. Source: Reactome |
| Cellular_component | voltage-gated calcium channel complex Traceable author statement Ref.1. Source: ProtInc |
| Molecular_function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW calcium ion bindingInferred from electronic annotation. Source: InterPro voltage-gated calcium channel activityTraceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| RXRB | P28702 | 3 | EBI-1055161,EBI-748576 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Alpha-1B-1 (identifier: Q00975-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Alpha-1B-2 (identifier: Q00975-2) The sequence of this isoform differs from the canonical sequence as follows: 2164-2339: GSGSVNGSPL...YHHPDQDHWC → AGSAVGFPNT...APPGLPTCPP |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||
Molecule processing | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 2339 | 2339 | Voltage-dependent N-type calcium channel subunit alpha-1B | PRO_0000053921 | ||||||||
Regions | ||||||||||||
| Topological domain | 1 – 95 | 95 | Cytoplasmic Potential | |||||||||
| Transmembrane | 96 – 114 | 19 | Helical; Name=S1 of repeat I; Potential | |||||||||
| Topological domain | 115 – 132 | 18 | Extracellular Potential | |||||||||
| Transmembrane | 133 – 152 | 20 | Helical; Name=S2 of repeat I; Potential | |||||||||
| Topological domain | 153 – 163 | 11 | Cytoplasmic Potential | |||||||||
| Transmembrane | 164 – 183 | 20 | Helical; Name=S3 of repeat I; Potential | |||||||||
| Topological domain | 184 – 187 | 4 | Extracellular Potential | |||||||||
| Transmembrane | 188 – 206 | 19 | Helical; Name=S4 of repeat I; Potential | |||||||||
| Topological domain | 207 – 225 | 19 | Cytoplasmic Potential | |||||||||
| Transmembrane | 226 – 245 | 20 | Helical; Name=S5 of repeat I; Potential | |||||||||
| Topological domain | 246 – 331 | 86 | Extracellular Potential | |||||||||
| Transmembrane | 332 – 356 | 25 | Helical; Name=S6 of repeat I; Potential | |||||||||
| Topological domain | 357 – 482 | 126 | Cytoplasmic Potential | |||||||||
| Transmembrane | 483 – 501 | 19 | Helical; Name=S1 of repeat II; Potential | |||||||||
| Topological domain | 502 – 516 | 15 | Extracellular Potential | |||||||||
| Transmembrane | 517 – 536 | 20 | Helical; Name=S2 of repeat II; Potential | |||||||||
| Topological domain | 537 – 544 | 8 | Cytoplasmic Potential | |||||||||
| Transmembrane | 545 – 562 | 18 | Helical; Name=S3 of repeat II; Potential | |||||||||
| Topological domain | 563 – 573 | 11 | Extracellular Potential | |||||||||
| Transmembrane | 574 – 592 | 19 | Helical; Name=S4 of repeat II; Potential | |||||||||
| Topological domain | 593 – 611 | 19 | Cytoplasmic Potential | |||||||||
| Transmembrane | 612 – 631 | 20 | Helical; Name=S5 of repeat II; Potential | |||||||||
| Topological domain | 632 – 684 | 53 | Extracellular Potential | |||||||||
| Transmembrane | 685 – 709 | 25 | Helical; Name=S6 of repeat II; Potential | |||||||||
| Topological domain | 710 – 1151 | 442 | Cytoplasmic Potential | |||||||||
| Transmembrane | 1152 – 1169 | 18 | Helical; Name=S1 of repeat III; Potential | |||||||||
| Topological domain | 1170 – 1185 | 16 | Extracellular Potential | |||||||||
| Transmembrane | 1186 – 1205 | 20 | Helical; Name=S2 of repeat III; Potential | |||||||||
| Topological domain | 1206 – 1217 | 12 | Cytoplasmic Potential | |||||||||
| Transmembrane | 1218 – 1236 | 19 | Helical; Name=S3 of repeat III; Potential | |||||||||
| Topological domain | 1237 – 1246 | 10 | Extracellular Potential | |||||||||
| Transmembrane | 1247 – 1265 | 19 | Helical; Name=S4 of repeat III; Potential | |||||||||
| Topological domain | 1266 – 1284 | 19 | Cytoplasmic Potential | |||||||||
| Transmembrane | 1285 – 1304 | 20 | Helical; Name=S5 of repeat III; Potential | |||||||||
| Topological domain | 1305 – 1391 | 87 | Extracellular Potential | |||||||||
| Transmembrane | 1392 – 1416 | 25 | Helical; Name=S6 of repeat III; Potential | |||||||||
| Topological domain | 1417 – 1471 | 55 | Cytoplasmic Potential | |||||||||
| Transmembrane | 1472 – 1490 | 19 | Helical; Name=S1 of repeat IV; Potential | |||||||||
| Topological domain | 1491 – 1505 | 15 | Extracellular Potential | |||||||||
| Transmembrane | 1506 – 1525 | 20 | Helical; Name=S2 of repeat IV; Potential | |||||||||
| Topological domain | 1526 – 1533 | 8 | Cytoplasmic Potential | |||||||||
| Transmembrane | 1534 – 1552 | 19 | Helical; Name=S3 of repeat IV; Potential | |||||||||
| Topological domain | 1553 – 1563 | 11 | Extracellular Potential | |||||||||
| Transmembrane | 1564 – 1582 | 19 | Helical; Name=S4 of repeat IV; Potential | |||||||||
| Topological domain | 1583 – 1601 | 19 | Cytoplasmic Potential | |||||||||
| Transmembrane | 1602 – 1621 | 20 | Helical; Name=S5 of repeat IV; Potential | |||||||||
| Topological domain | 1622 – 1683 | 62 | Extracellular Potential | |||||||||
| Transmembrane | 1684 – 1708 | 25 | Helical; Name=S6 of repeat IV; Potential | |||||||||
| Topological domain | 1709 – 2339 | 631 | Cytoplasmic Potential | |||||||||
| Repeat | 82 – 359 | 278 | I | |||||||||
| Repeat | 468 – 712 | 245 | II | |||||||||
| Repeat | 1137 – 1419 | 283 | III | |||||||||
| Repeat | 1456 – 1711 | 256 | IV | |||||||||
| Domain | 1724 – 1759 | 36 | EF-hand | |||||||||
| Nucleotide binding | 451 – 458 | 8 | ATP Potential | |||||||||
| Calcium binding | 1737 – 1748 | 12 | By similarity | |||||||||
| Region | 379 – 396 | 18 | Binding to the beta subunit By similarity | |||||||||
| Compositional bias | 2050 – 2054 | 5 | Poly-His | |||||||||
| Compositional bias | 2118 – 2122 | 5 | Poly-Ser | |||||||||
Sites | ||||||||||||
| Site | 314 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||
| Site | 663 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||
| Site | 1365 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||
| Site | 1655 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||
Amino acid modifications | ||||||||||||
| Modified residue | 745 | 1 | Phosphoserine By similarity | |||||||||
| Modified residue | 783 | 1 | Phosphoserine By similarity | |||||||||
| Modified residue | 1719 | 1 | Phosphoserine; by PKA Potential | |||||||||
| Modified residue | 2256 | 1 | Phosphoserine By similarity | |||||||||
| Glycosylation | 256 | 1 | N-linked (GlcNAc...) Potential | |||||||||
| Glycosylation | 1563 | 1 | N-linked (GlcNAc...) Potential | |||||||||
| Glycosylation | 1675 | 1 | N-linked (GlcNAc...) Potential | |||||||||
Natural variations | ||||||||||||
| Alternative sequence | 2164 – 2339 | 176 | GSGSV…QDHWC → AGSAVGFPNTTPCCRETPSA SPWPLALELALTLTWGSVWT VRPLSTPCLRTRSLSRRLWP PTRAAPPGLPTCPP in isoform Alpha-1B-2. | VSP_000882 | ||||||||
| Natural variant | 167 | 1 | N → K. Corresponds to variant rs4422842 [ dbSNP | Ensembl ]. | VAR_048741 | ||||||||
| Natural variant | 862 | 1 | A → S. Corresponds to variant rs7873074 [ dbSNP | Ensembl ]. | VAR_061100 | ||||||||
| Natural variant | 996 | 1 | T → A. Corresponds to variant rs11137342 [ dbSNP | Ensembl ]. | VAR_061101 | ||||||||
| Natural variant | 1436 | 1 | E → K. Corresponds to variant rs12377346 [ dbSNP | Ensembl ]. | VAR_048742 | ||||||||
| Natural variant | 1500 | 1 | E → K. Corresponds to variant rs12377346 [ dbSNP | Ensembl ]. | VAR_048743 | ||||||||
Secondary structure | ||||||||||||
Helix Strand Turn | ||||||||||||
| Helix | 1244 – 1263 | 20 | ||||||||||
| Turn | 1264 – 1266 | 3 | ||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel." Williams M.E., Brust P.F., Feldman D.H., Patthi S., Simerson S., Maroufi A., McCue A.F., Velicelebi G., Ellis S.B., Harpold M.M. Science 257:389-395(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-1B-1 AND ALPHA-1B-2). Tissue: Brain. |
| [2] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "Isolation and characterization of the 5'-upstream region of the human N-type calcium channel alpha1B subunit gene. Chromosomal localization and promoter analysis." Kim D.S., Jung H.-H., Park S.-H., Chin H. J. Biol. Chem. 272:5098-5104(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-94. Tissue: Lung fibroblast. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M94172 mRNA. Translation: AAA51897.1. M94173 mRNA. Translation: AAA51898.1. AL591424, AL772363 Genomic DNA. Translation: CAI40687.1. AL772363, AL591424 Genomic DNA. Translation: CAI17144.1. U76666 Genomic DNA. Translation: AAC51138.1. | ||||||||||||
| IPI | IPI00025477. IPI00220431. | ||||||||||||
| PIR | A42566. T45115. | ||||||||||||
| RefSeq | NP_000709.1. NM_000718.3. NP_001230741.1. NM_001243812.1. | ||||||||||||
| UniGene | Hs.495522. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q00975. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q00975. 3 interactions. | ||||||||||||
| MINT | MINT-102376. | ||||||||||||
| STRING | 9606.ENSP00000277549. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q00975. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 1705854. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q00975. | ||||||||||||
| PRIDE | Q00975. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000371372; ENSP00000360423; ENSG00000148408. | ||||||||||||
| GeneID | 774. | ||||||||||||
| KEGG | hsa:774. | ||||||||||||
| UCSC | uc004cog.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 774. | ||||||||||||
| GeneCards | GC09P140772. | ||||||||||||
| HGNC | HGNC:1389. CACNA1B. | ||||||||||||
| HPA | HPA044347. | ||||||||||||
| MIM | 601012. gene. | ||||||||||||
| neXtProt | NX_Q00975. | ||||||||||||
| PharmGKB | PA26008. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG1226. | ||||||||||||
| HOGENOM | HOG000231530. | ||||||||||||
| HOVERGEN | HBG050763. | ||||||||||||
| KO | K04849. | ||||||||||||
| OrthoDB | EOG48KR9C. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_13685. Neuronal System. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q00975. | ||||||||||||
| Bgee | Q00975. | ||||||||||||
| CleanEx | HS_CACNA1B. | ||||||||||||
| Genevestigator | Q00975. | ||||||||||||
| GermOnline | ENSG00000148408. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.20.120.350. 4 hits. | ||||||||||||
| InterPro | IPR002048. EF_hand_dom. IPR005821. Ion_trans_dom. IPR027359. K_channel_four-helix_dom. IPR014873. VDCC_a1su_IQ. IPR005447. VDCC_N_a1su. IPR002077. VDCCAlpha1. [Graphical view] | ||||||||||||
| PANTHER | PTHR10037:SF131. PTHR10037:SF131. 1 hit. | ||||||||||||
| Pfam | PF08763. Ca_chan_IQ. 1 hit. PF00520. Ion_trans. 4 hits. [Graphical view] | ||||||||||||
| PRINTS | PR00167. CACHANNEL. PR01631. NVDCCALPHA1. | ||||||||||||
| SMART | SM01062. Ca_chan_IQ. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50222. EF_HAND_2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | Q00975. | ||||||||||||
| ChEMBL | CHEMBL4478. | ||||||||||||
| DrugBank | DB00381. Amlodipine. DB00996. Gabapentin. | ||||||||||||
| GenomeRNAi | 774. | ||||||||||||
| NextBio | 3128. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CAC1B_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q00975 Secondary accession number(s): B1AQK5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
